Biotech Review of the Year: Six months on

It's hard to believe that six months have passed since we released the 11th edition of our Biotech Review of the Year publication.

Our editors, Greg Bacon, Xisca Borrás, and Will Hewitt, thought now would be a great time to catch up and discuss any developments since the launch.

You can also find written updates on the following articles here:

• Integrating generative AI into the life science ecosystem – five tips for success
• Revision of the EU pharmaceutical law regime – what does it mean for biotech companies?
• The first 12 months of the Unified Patent Court
• The application of G2/21 by the Court of Appeal
• Strategic considerations for partnering with CDMOs for cell and gene therapies
• Biotech settlement agreements – a competition law checklist